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Abstract 
45S5 Bioglass® (45S5BG - 45 wt.% SiO2, 24.5 wt.% CaO, 24.5 wt.% Na2O and 6 wt.% P2O5 glass forming system) is a 
frequently applied type A bioactive material, forming an inherent bond to bone and soft tissue. Recent studies for nanometer 
sized bioactive glasses (nBG) have indicated their great potential for several biomedical applications. It is recognized that cost-
efficient processing routes are required for the development of submicron bioactive glasses, given the advantages associated with 
the nanoscale. In this study, the potential of top-down processing of 45S5BG by wet comminution in a stirred media mill is 
investigated and the key importance of the used solvents is revealed: whereas bioactive submicron particles can be produced in 
organic solvents, as shown exemplarily for n-pentanol, bioactivity is lost after processing in water. Analysis of the elemental 
constituents in the solid phase by ICP-OES indicates enhanced dissolution during processing in water, i.e. the glass composition 
is changing during processing. In n-pentanol the overall composition and structure is maintained and only the formation of 
surface carbonates is observed; flake-like particles are obtained. As a marker for bioactivity in vitro hydroxycarbonate apatite 
formation as determined by FTIR is used; biocompatibility is addressed by in vitro incubation with osteoblast like MG-63 cells. 
All-together, we propose wet comminution under controlled conditions as an appropriate technique to produce submicrometer 
bioactive glass particles with enhanced bioactivity. 
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1. Introduction 
45S5 Bioglass® is a class A bioactive glass (45S5BG - 45 wt.% SiO2, 24.5 wt.% CaO, 24.5 wt.% Na2O and 6 wt.% 
P2O5 glass forming system) [1] capable of inherently bonding to human bone [2] and soft tissue [3] in physiological 
media. The proposed mechanism [4, 5] for bond formation includes five material-based sequences and six steps on 
the cellular level, whereby the release of soluble ion species from the glass and the formation of a surface apatite 
play a major role: the release of sodium and calcium leads to an increase of local pH and thus a highly porous silica 
gel layer on top of the glass (an ideal adsorptive for growth factors and stem cells) is formed by hydrolysis; released 
water-soluble ion species are genetically active on the cellular level and mitosis of osteoprogenitor cells [6] and 
angiogenesis are stimulated [7]; in vicinity of glass surface a supersaturation with respect to carbonate 
hydroxyapatite is being built up and crystallization takes place. The formation and crystallization of this defective 
hydroxy-carbonate surface layer (very similar to inorganic parts in human bone) is a prerequisite for bioactivity and 
bonding to tissue [8]. It is recognized that the described mechanism relays on ion-exchange with the surrounding 
medium by dissolution and precipitation mechanisms. 
Although several studies have indicated enhanced bioactivity of bioactive glasses on the nanoscale (see e.g. [9-13]), 
the currently applied bioglass particulates (from conventional glass melting routes) typically exhibit particle sizes of 
several tens to hundred micrometers. Up to now, bottom-up processing routes (e.g. sol-gel processing [14] and flame 
spray pyrolysis[15]) are used for the production of nanoscaled bioglasses (nBG). Given the potential disadvantages 
of bottom-up synthesis routes (e.g. toxic precursors, costly, limited in composition), top-down processing by wet 
grinding in stirred media mills (under controlled conditions) offers an attractive alternative towards submicron 
(bioactive) materials [12; 16-22]. 
In the present communication, wet comminution of 45S5BG in stirred media mills is discussed. It was found that the 
in vitro bioactivity and biocompatibility of 45S5BG after processing in n-pentanol increased; in addition, the mass 
specific surface area increased by a factor of 30 with respect to the feed material. The resulting product exhibits a 
flake-like morphology. After processing in water, bioactivity is lost entirely and spongy porous products are 
obtained. The mechanisms leading to the different products are briefly discussed. 
 
2. Experimental 
2.1. Bioglass® 45S5BG feed material 
Commercially available 45S5 Bioglass® powder with nominal particle size x50,3 of 22 μm (from static light 
scattering) was used. SEM analysis confirmed that the powder is comprised of sharp-edge shards. By ICP-OES 
analysis the nominal composition of 45S5BG was found: 43.6 ± 2.5 wt.% SiO2, 24.6 ± 0.9 wt.% Na2O, 23.3 ± 
0.1 wt.% CaO, 5.4 ± 0.1 wt.% P2O5. 
2.2. Stirred media milling (PE075, Netzsch, Germany) 
The vertically aligned laboratory stirred media mill PE075 (loaded with approx. 1.8 kg milling beads, 2mm diameter, 
Tosho Inc., Japan) was used to comminute the BG dispersions (3 wt.% solid). Used solvents were water from a 
Millipore Simplicity device and n-pentanol (>98 %, VWR, Germany). Tip speed of the three disc stirrer was 4.9 m/s 
for the experiments. Temperature was maintained at 10°C by external cooling. After sampling, solids were separated 
from the liquid by centrifugation; drying was performed in an oven (120°C, 24h). 
2.3. Short term in vitro bioactivity 
Carbonate hydroxyapatite formation in simulated body fluid (SBF) was used as in vitro marker for bioactivity [23]: 
100 mg of the sample were immersed in 50 mL SBF (all chemicals analytical grade, Sigma-Aldrich). The immersed 
samples were kept slightly agitated at 37°C (Unimax 1010M incubator, Heidolph Instruments, Germany). After 
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sampling (4h, 8h, 1d, 3d, 7d) and centrifugation, the obtained powders were washed with acetone and water and 
were dried at 60°C for 24h. 
2.4. In vitro biocompatibility 
Biocompatibility studies were performed with MG63 osteoblast-like cells (ATCC®, Sigma Aldrich). DMEM 
(Gibco®) supplemented with 10 vol.% fetal calf serum (Sigma Aldrich) and 1 vol.% penicillin and streptomycin 
(Biochrom) was used for cultivation. Cell concentrations were obtained by a Thoma counting chamber. Dry heat 
sterilization (160°C, 2h) of the samples was performed prior to dispersion in the cell growth medium (cell density 
was set initially by inoculation to 105 cells / ml). Cultivation in presence of the powder samples was performed for 
48 h. Cell viability in terms of mitochondrial activity was characterized by the WST-8 assay, i.e. after incubation the 
washed cells are further incubated (90 min) in a mixture of WST-8 reagent (Sigma Aldrich) and cell culture medium. 
Photometric concentration determinations are performed at 450 nm (Specord 40, Analytik Jena). Further details 
about the cell biology study have been presented elsewhere [22]. 
2.5. Scanning electron microscopy (Ultra FE-SEM Gemini Ultra 55, Carl Zeiss, Germany) 
For SEM imaging, powders were embedded in silver containing conductive glue. Accelerating voltage and finale 
aperture was 2 kV and 10 μm, respectively. Secondary electrons were used for imaging. 
2.6. Nitrogen sorption analysis (Nova 4200e, Quantachrome Inc., USA) 
Sample degassing was performed at 120°C for 2h under vacuum. Measurements were performed at liquid nitrogen 
temperature. Mass specific surface areas were obtained by applying BET theory in the respective pressure region of 
the recorded adsorption data [24]. 
2.7. Infrared spectroscopy (FTS 3100 Spectrometer, Varian, USA) 
Recordings were performed from 3800 cm-1 to 400 cm-1 with a spectral resolution of 2 cm-1. Prior to measurements 
samples were dispersed (1/1000 wt./wt.) in KBr (UVASol, for IR spectroscopy, Merck KGaA, Germany). Data is 
normalized to maximum absorbance; base line corrections were performed manually. 
2.8. Sample digestion and ICP-OES analyses (Optima 8300, Perkin Elmer / Multiwave 3000 Anton Paar) 
Prior to analysis, solids were digested in a microwave. The used digestion solution was comprised of 2 mL 
hydrofluoric acid (48 %, Carl Roth), 2 mL nitric acid (69 %, Carl Roth), and 4 mL hydrochloric acid (> 35 %, Carl 
Roth) – all chemicals supra purity. Dissolved boric acid (2 g / 40 mL; > 99.8 %, Carl Roth) was added after 
digestion and the final volume was adjusted 250 mL. The samples were fed with a feed rate of 1.8 mL/min into a 
nebulizer (Mira Mist, Perkin Elmer) and the resulting aerosol was transferred for measurements into the argon 
plasma (1400 W). Gas flow rates were 10 L/min, 0.6 L/min, and 0.2 L/min for the plasma, nebulizer, and auxiliary 
gas. A five point calibration was performed in the appropriate concentration range using dilutions derived from 
elemental standards (1 g/L) for ICP-OES analysis (Carl Roth). 
 
537 Stefan Romeis et al. /  Procedia Engineering  102 ( 2015 )  534 – 541 
3. Results and Discussion 
3.1. Wet comminution in stirred media mills 
 
Fig. 1. Mass specific surface areas after comminution for different process times in the solvents water (open symbols) and n-pentanol (closed 
symbols). 
The mass specific surface areas obtained from N2 sorption measurements are depicted in Fig. 1. As can be seen, 
higher areas at a given process time are obtained after processing in H2O: in contrast to n-pentanol mass specific 
surface areas are increased by a factor of approx. 2 – an effect that cannot be solely attributed to differences in 
viscosity of the solvents (10°C - H2O 1.3 mPas / n-pentanol - 5.9 mPas) [12; 20; 25]. Using an organic solvent the 
solubility of the glass (and its constituents) is significantly lowered (influence of the relative permittivity on 
solubility is well documented – see e.g. [26; 27]) and we found pore formation (an indicator for solubility– data not 
shown) only for processing in H2O. It can thus be concluded that interactions of the glass with the surrounding water 
lead to the significantly increased surface areas. 
 
Fig. 2. FT-IR spectra of the obtained products for processing in water (left) and n-pentanol (right). 
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Structural characterization by vibrational spectroscopy (see Fig. 2) and elemental analysis of the obtained solids (see 
Tab. 1) are in agreement. Upon comminution in water, we find significant changes of the original glass structure, 
with its characteristic features at 1020 cm-1 (asymmetric Si-O-Si), the non-binding oxygen at 930 cm-1, and a weaker 
band at 500 cm-1 (symmetric Si-O-Si): the feature initially found at 500 cm-1 shifts to 450 cm-1 and indicates a loss 
of the network modifier sodium. The loss of the NBO band within the broadening feature originally centered at 
1020 cm-1 indicates a degradation of the glass network resulting in an increasing spread of bond length and bond 
angles. Furthermore, the formation of carbonate is indicated by the rising features at 1500 cm-1 and 1430 cm-1: 
starting from surface adsorbed species (as indicated by the single band at 1450 cm-1), free carbonates are formed in 
course of the reaction. In stark contrast only a formation of surface carbonate species (relative intensity of the 
feature at 1450 cm-1 is increased) and a slight shift of the feature centered at 500 cm-1 are observed during 
processing in n-pentanol. From elemental analysis (after microwave digestion) by ICP-OES analysis of the obtained 
products complementary information is derived. 
Table 1. Relative compositions (mass fractions) of the products after various processing times determined by ICP-OES 
analysis. 
Solvent Process time / h  Na2O / SiO2 
wt./wt. 
CaO / SiO2 
wt./wt. 
P2O5 / SiO2 
wt./wt. 
Feed material / 0.57 ± 0.04 0.53 ± 0.04 0.12 ± 0.08 
n-pentanol 5 0.53 ± 0.04 0.55 ± 0.01 0.13 ± 0.04 
n-pentanol 24 0.53 ± 0.04 0.54 ± 0.04 0.12 ± 0.01 
H2O 5 0.25 ± 0.03 0.65 ± 0.02 0.17 ± 0.04 
H2O 18 0.19 ± 0.04 0.62 ± 0.04 0.17 ± 0.01 
H2O 24 0.19 ± 0.03 0.64 ± 0.02 0.14 ± 0.01 
 
Table 1 displays the relative compositions of the obtained products after various processing times. Due to the 
formation of carbonates involving atmospheric CO2 and the accompanied increase of total sample mass, data had to 
be normalized to silica (silica is used as an internal standard). As can be seen, the relative amount of the different 
components does not change significantly during processing in n-pentanol; during processing in water, however, 
sodium is lost and the obtained powders are enriched in calcium and phosphorous. 
 
 
Fig. 3. Morphology of the different materials: (A) feed, (B) 24h processing in H2O, and (C) 24h processing in n-pentanol. 
Fig. 3 displays the morphology of the feed material (A) and the obtained powders (B and C). It can be seen that a 
spongy morphology is obtained after processing in water (B), an effect caused by leaching and the accompanied 
changes of the glass structure in course of comminution. In stark contrast, products from n-pentanol (C) show a 
flake-like morphology with lateral dimensions in the micron scale. The height of the flakes, however, accounts for 
only some tens of nanometers. We associate the formation of the platelets with ductile (plastic) deformation of the 
glass particles as observed for vitreous silica particles below 1 μm [28-32]. 
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3.2. Short term acellular in vitro bioactivity 
 
Fig. 4. Short term acellular in vitro bioactivity: Left - FT-IR spectra after immersion– apatite formation indicated by red arrows. Right: SEM 
images prior (upper row) and after immersion in SBF (lower row). 
Short term in vitro bioactivity was assessed by immersion in SBF and the crystallization of the apatite layer is 
judged on the basis of infrared spectra. As can be seen in Fig. 4 (left) an amorphous apatite layer is formed for the 
feed material within the first day (broad feature at ~590 cm-1). Clear indications for crystallization are found after 
three days (amorphous broad feature splits into two separate features at 600 cm-1 and 570 cm-1). Whereas no apatite 
formation can be observed for the powder processed in water even within 7d, crystalline apatite for the glass from n-
pentanol is already found after 1d of soaking. This clearly indicates enhanced bioactivity of the comminution 
product. From the accompanying SEM images in Fig. 4 it can be concluded that the apatite is formed on top of the 
flaky particles. 
3.3. Biocompatibility 
 
Fig. 5. Left: Mitochondrial activity of the feed (circles) and the comminution product (triangles). Right: Fluorescence microscope image (staining 
– nuclei blue; mineralized phases green; cytoskeleton red) after incubation of 200 μg/mL powder from n-pentanol processing. 
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Biocompatibility of the powders was judged on the basis of the mitochondrial activity. As can be seen in Fig. 5 (left) 
no cell toxic effects (for MG-63 cells) were found even after administering the highest concentration (200 μg/mL) of 
the product from comminution. Fluorescence microscopy (Fig. 5 - right image) revealed that the cells grow directly 
on and onto the mineralized layer (stained green) [22]. 
 
4. Conclusion 
This paper has discussed the wet comminution in stirred media mills of 45S5BG as an alternative process to produce 
submicron 45S5 Bioglass® particles. Based on the presented findings it can be concluded that grinding under 
controlled conditions is an attractive alternative towards the production of submicron Bioglass® particles with 
enhanced bioactivity. The dominant role of the solvent in relation to the properties of the obtained particles, in 
particular in terms of structure and composition, has been discussed: only in solvents of low relative dielectric 
constant successful top-down processing of bioactive glass powder is possible. 
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